Statement from Drug Science regarding Project Twenty 21 and its official industry partners. For immediate release: 5th March 2021 Drug Science would like to clarify the aims of the Project Twenty 21 initiative and who its industry partners are. This follows recent misleading statements from Kanabo, claiming an unauthorised association with our project. Project Twenty21  …

Authors: Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt, H Valerie Curran Published: February 17, 2021 This Drug Science research was published in the Journal of Psychopharmacology. For recreational users, the estimated chances of becoming dependent on cannabis after any lifetime exposure is 8.9%, which is considerably lower than for cocaine (20.9%), alcohol  …

In this update, we reveal the latest data from Project Twenty21 and unveil a new online form that patients can use to share their story and experience with medical cannabis through Project Twenty21. We also answer some of the most frequent questions that are asked about medical cannabis through Project Twenty21, and clarify the step-by-step  …

A Closer Look at the Families Struggling to Cope with the Huge Financial and Personal Burden of Accessing Medical Cannabis to Treat Childhood Epilepsy By Danielle Johnson, Clinical Scientist in Neurophysiology and member of the Medical Cannabis Working Group at Drug Science In recent years, the case for medical cannabis as a treatment for drug-resistant  …

Download our letter to the Advisory Council on the Misuse of Drugs   Dear Owen Bowden-Jones I am writing on behalf of Drug Science in relation to the ACMD update report on medical cannabis last November. The Drug Science Medical Cannabis Working Group (MCWG) has now had time to discuss your report and I wanted  …

There is little doubt that this last year has been a hugely turbulent one for everyone. At Project Twenty21, we have remained innately focused on delivering our objectives of improving access of medical cannabis for patients, and collecting a substantial evidence base on the efficacy and safety profile of medical cannabis across a range of  …

In November 2019, Drug Science launched Project Twenty21 – Europe’s first and biggest national medical cannabis registry. The project was set up for simple reasons. Even after legislation around cannabis based medical products (CBMPs) was changed by the UK Government, too many people are still unable to access these treatments. The cost of these medications  …